The rates of dementia in patients randomized to GLP‐1 RA were significantly lower than those randomized to placebo (hazard ratio [HR]: 0.47 [95% confidence interval [CI]: 0.25–0.86]). The gene discussed is GLP1R; the disease is dementia.